Vin Tangpricha is an Endocrinology/Metabolic physician affiliated with Emory University. OpenAlex indexes 473 publications with 29,657 citations (h-index 78); ClinicalTrials.gov lists 14 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Progesterone in Gender Affirming Hormone Therapy Study
Sponsor: Emory University
- Systems Biological Assessment of Statin Effect on Vaccine Responses
Sponsor: Emory University
- Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
32.4%Insulin Analog22.4%Lantus Solostar38%Novolog Flexpen34%Novolog29%Part D<11 patientsSGLT2 inhibitor10%Jardiance100%Part D<11 patientsGenitourinary & hormones
26.4%Estrogen18.4%Estradiol63%Estradiol (Once Weekly)37%Part D<11 patientsAndrogen8%Testosterone Cypionate100%Part D<11 patientsHormonal (systemic)
25.2%l-Thyroxine20.4%Synthroid51%Levothyroxine Sodium49%Part D<11 patientsParathyroid Hormone Analog4.8%Forteo100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2011$128,250K23AR054334 - Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2010$128,250K23AR054334 - Role of T-cells in Osteoporosis in Women Undergoing Surgical Menopause
Emory University
FY2009$128,250K23AR054334
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
Laurence Sperling, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”